SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-032828
Filing Date
2019-08-22
Accepted
2019-08-22 16:54:34
Documents
3
Period of Report
2019-08-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - KHK FIFTH AND SIXTH SUPPLEMENT reta-8k_20190822.htm 8-K 38812
2 EX-10.1_KHK 5TH SUPPLEMENT reta-ex101_8.htm EX-10.1 45060
3 EX-10.2 KHK_6TH SUPPLEMENT reta-ex102_73.htm EX-10.2 30679
  Complete submission text file 0001564590-19-032828.txt   115653
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 191046531
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences